Skip to content

Clinical trials

Expanded access Precursor Cell Lymphoblastic Leukemia-Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Expanded access Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available8
Available6
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Autolus Limited1
Barbara Ann Karmanos Cancer Institute1
Christopher Dvorak1
ERYtech Pharma1
Jazz Pharmaceuticals1
Joanne Kurtzberg, MD1
Kathleen Ludwig1
Kite, A Gilead Company1
Kura Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma15
Leukemia, Myeloid, Acute6
Myelodysplastic Syndromes4
Leukemia3
Lymphoma3
Burkitt Lymphoma2
Hematologic Neoplasms2
Immune System Diseases2
Immunologic Deficiency Syndromes2
Immunoproliferative Disorders2

Trials

Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.